Medclair AB (NGM:MCLR)
Sweden · Delayed Price · Currency is SEK 2.780
-0.020 (-0.71%)
At close: Sep 24, 2026
Medclair AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 53.14 | 52.08 | 32.2 | 39.85 | 24.89 | 10.69 | |
Revenue Growth | 34.86% | 61.74% | -19.20% | 60.13% | 132.75% | 71.42% |
Cost of Revenue | 19.27 | 18.02 | 12.6 | 17.66 | 7.76 | 5.8 |
Gross Profit | 33.87 | 34.06 | 19.6 | 22.2 | 17.13 | 4.89 |
Selling, General & Admin | 30.61 | 27.39 | 24.31 | 21.91 | 19 | 15.32 |
Other Operating Expenses | -3.6 | -4.03 | -3.82 | -2.61 | -3.28 | -2.72 |
Operating Expenses | 32.02 | 28.36 | 25.77 | 24.83 | 21.1 | 17.71 |
Operating Income | 1.85 | 5.7 | -6.17 | -2.63 | -3.97 | -12.82 |
Interest Expense | -0.2 | -0.59 | -0.23 | -0.37 | -0.08 | -0.11 |
Interest & Investment Income | 0.1 | 0.1 | 0.19 | 0.2 | - | - |
Currency Exchange Gain (Loss) | -1.03 | -1.03 | -0.57 | -0.83 | -0.37 | -0.09 |
Other Non Operating Income (Expenses) | 0.3 | - | - | -0 | - | - |
EBT Excluding Unusual Items | 1.01 | 4.19 | -6.76 | -3.63 | -4.42 | -13.01 |
Gain (Loss) on Sale of Assets | 0.47 | 0.47 | 6.1 | 0.85 | -0.57 | - |
Pretax Income | 1.48 | 4.65 | -0.66 | -2.78 | -4.99 | -13.01 |
Income Tax Expense | - | - | - | 0.01 | 0.01 | 0.01 |
Net Income | 1.48 | 4.65 | -0.66 | -2.79 | -5 | -13.02 |
Net Income to Common | 1.48 | 4.65 | -0.66 | -2.79 | -5 | -13.02 |
Net Income Growth | -27.07% | - | - | - | - | - |
Shares Outstanding (Basic) | 82 | 78 | 66 | 93 | 83 | 81 |
Shares Outstanding (Diluted) | 82 | 78 | 66 | 93 | 83 | 81 |
Shares Change | 17.97% | 16.79% | -28.47% | 11.40% | 2.41% | - |
EPS (Basic) | 0.02 | 0.06 | -0.01 | -0.03 | -0.06 | -0.16 |
EPS (Diluted) | 0.02 | 0.06 | -0.01 | -0.03 | -0.06 | -0.16 |
EPS Growth | -38.18% | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.35 | 6.91 | 1.19 | 4.23 | -11.77 | -8.68 |
Free Cash Flow Per Share | 0.02 | 0.09 | 0.02 | 0.05 | -0.14 | -0.11 |
Gross Margin | 63.73% | 65.39% | 60.86% | 55.70% | 68.83% | 45.76% |
Operating Margin | 3.47% | 10.94% | -19.15% | -6.60% | -15.95% | -119.87% |
Profit Margin | 2.78% | 8.93% | -2.06% | -6.99% | -20.09% | -121.76% |
Free Cash Flow Margin | 2.53% | 13.26% | 3.70% | 10.61% | -47.30% | -81.16% |
EBITDA | 6.55 | 10.41 | -1.49 | 1.88 | 0.12 | -8.85 |
EBITDA Margin | 12.34% | 19.99% | -4.64% | 4.73% | 0.47% | -82.75% |
D&A For EBITDA | 4.71 | 4.71 | 4.67 | 4.52 | 4.09 | 3.97 |
EBIT | 1.85 | 5.7 | -6.17 | -2.63 | -3.97 | -12.82 |
EBIT Margin | 3.47% | 10.94% | -19.15% | -6.60% | -15.95% | -119.87% |
Revenue as Reported | 56.58 | 56.58 | 36.71 | 43.32 | 28.44 | 13.41 |